Cardioprotective effect of MCC-135 is associated with inhibition of Ca2+ overload in ischemic/reperfused hearts

European Journal of Pharmacology
Naoya Satoh, Yoshimi Kitada

Abstract

Calcium (Ca2+) overload is an important pathophysiological factor in myocardial ischemic/reperfusion injury. We investigated the effects of a cardioprotective drug, MCC-135, 5-methyl-2-(1-piperazinyl) benzenesulfonic acid monohydrate, on (1) cardiac contractile dysfunction and Ca2+ overload induced by ischemia and reperfusion, and (2) the Na+/Ca2+ exchanger in Langendorff-perfused rat hearts. Low-flow 45-min ischemia and 30-min reperfusion decreased developed tension and increased ventricular Ca2+ content, effects which were ameliorated by MCC-135 and amiloride given after reperfusion. Combination of intracellular Na+ overload induced by monensin (Na+ ionophore; 5 microM) and zero-flow 15-min ischemia followed by 30-min reperfusion resulted in a decrease in developed tension and in the intracellular Na+-dependent increase in ventricular Ca2+ content. MCC-135 and the highest dose of amiloride given after reperfusion reduced the increase in ventricular Ca2+ content, whereas developed tension was increased only with MCC-135. These results suggest that the cardioprotective effect of MCC-135 in ischemia/reperfusion is associated with suppression of Ca2+ overload and is attributable to inhibition of intracellular Na+-dependent Ca2+ i...Continue Reading

References

Feb 1, 1990·Journal of Cardiovascular Pharmacology·A TosakiP Braquet
Feb 1, 1986·Journal of Molecular and Cellular Cardiology·R H KennedyT M Brody
Jan 28, 1987·European Journal of Pharmacology·J WattsT Harwell
Nov 1, 1985·The Journal of Clinical Investigation·E Braunwald, R A Kloner
Aug 1, 1984·Circulation Research·W G NaylerM J Daly
May 1, 1994·Cardiovascular Research·H S Silverman, M D Stern
May 1, 1996·Basic Research in Cardiology·H M PiperD Garcia-Dorado
Oct 1, 1996·Journal of Cardiovascular Pharmacology·N KhandoudiA Bril
Dec 24, 1997·JAMA : the Journal of the American Medical Association·W D WeaverF Ribichini
May 30, 1998·Journal of Molecular and Cellular Cardiology·J G Van EmousC J Van Echteld
Apr 30, 1999·Physiological Reviews·R Bolli, E Marbán
Sep 11, 1999·The American Journal of Cardiology·M Avkiran
Dec 10, 1999·The Annals of Thoracic Surgery·G J GrossD C Warltier
Aug 22, 2001·American Journal of Physiology. Heart and Circulatory Physiology·C L EliasL V Hryshko
Apr 17, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Shingo SekiSeibu Mochizuki
Apr 18, 2002·British Journal of Pharmacology·Keiji KusumotoToshifumi Watanabe
May 4, 2002·Heart Failure Reviews·Andrew A WolffRoberto Ferrari
Oct 24, 2002·Journal of Molecular and Cellular Cardiology·Stephen P Nighswander-RempelHenry H Mantsch
Feb 28, 2003·The Annals of Thoracic Surgery·H Michael PiperClaudia Schäfer
Dec 12, 2003·The Annals of Thoracic Surgery·William M YarbroughFrancis G Spinale

❮ Previous
Next ❯

Citations

Mar 31, 2012·International Journal of Cardiology·Martinus I F J OerlemansJoost P G Sluijter
Feb 15, 2007·Journal of Pharmacological Sciences·Hisashi KawasumiYoshimi Kitada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.